Wednesday, December 19, 2018

Advil meet Excedrin: Pfizer and GSK are merging their consumer healthcare businesses

Advil meet Excedrin: Pfizer and GSK are merging their consumer healthcare businesses

12/19/2018=31,49,69,24,42..353 day 12 left
GlaxoSmithKline=82,89/24th prime on a day with 24 numerology
Pfizer=82
merger=66,33,39,96
"the new company would have combined sales of $12.7 billion a year."..127/31st prime on a day with 31 numerology


Advil meet Excedrin: Pfizer and GSK are merging their consumer healthcare businesses" = 

409
409/49 on a day with 49 numerology
Hong Kong (CNN Business)GlaxoSmithKline and Pfizer are combining their consumer healthcare businesses in a multibillion-dollar merger.
The two pharmaceutical giants — which own household names like Advil and Tums — saidWednesday that the new company would have combined sales of $12.7 billion a year.
The merger will bring together Pfizer's big sellers like Centrum and Caltrate with GSK's top brands, including Excedrin and Nicorette.
GSK (GSK), which is headquartered in Britain, will own just over two-thirds of the joint venture, with US-based Pfizer (PFE) holding the rest.

No comments:

Post a Comment